Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Drebrin restricts rotavirus entry by inhibiting dynamin-mediated endocytosis.

Li B, Ding S, Feng N, Mooney N, Ooi YS, Ren L, Diep J, Kelly MR, Yasukawa LL, Patton JT, Yamazaki H, Shirao T, Jackson PK, Greenberg HB.

Proc Natl Acad Sci U S A. 2017 May 2;114(18):E3642-E3651. doi: 10.1073/pnas.1619266114. Epub 2017 Apr 17.

2.

Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages.

Callaway HM, Feng KH, Lee DW, Allison AB, Pinard M, McKenna R, Agbandje-McKenna M, Hafenstein S, Parrish CR.

J Virol. 2017 Jan 3;91(2). pii: e01871-16. doi: 10.1128/JVI.01871-16. Print 2017 Jan 15.

3.

Cellular transduction mechanisms of adeno-associated viral vectors.

Berry GE, Asokan A.

Curr Opin Virol. 2016 Dec;21:54-60. doi: 10.1016/j.coviro.2016.08.001. Epub 2016 Aug 18. Review.

4.

Two host microRNAs influence WSSV replication via STAT gene regulation.

Huang Y, Wang W, Ren Q.

Sci Rep. 2016 Mar 31;6:23643. doi: 10.1038/srep23643.

5.

The SUMOylation Pathway Restricts Gene Transduction by Adeno-Associated Viruses.

Hölscher C, Sonntag F, Henrich K, Chen Q, Beneke J, Matula P, Rohr K, Kaderali L, Beil N, Erfle H, Kleinschmidt JA, Müller M.

PLoS Pathog. 2015 Dec 1;11(12):e1005281. doi: 10.1371/journal.ppat.1005281. eCollection 2015 Dec.

6.

Adeno-associated Virus as a Mammalian DNA Vector.

Salganik M, Hirsch ML, Samulski RJ.

Microbiol Spectr. 2015 Aug;3(4). doi: 10.1128/microbiolspec.MDNA3-0052-2014. Review.

7.

Enhancing gene delivery of adeno-associated viruses by cell-permeable peptides.

Liu Y, Kim YJ, Ji M, Fang J, Siriwon N, Zhang LI, Wang P.

Mol Ther Methods Clin Dev. 2014 Feb 19;1:12. doi: 10.1038/mtm.2013.12. eCollection 2014.

8.

Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction.

Nonnenmacher ME, Cintrat JC, Gillet D, Weber T.

J Virol. 2015 Feb;89(3):1673-87. doi: 10.1128/JVI.02520-14. Epub 2014 Nov 19.

9.

Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms.

Weinberg MS, Nicolson S, Bhatt AP, McLendon M, Li C, Samulski RJ.

J Virol. 2014 Nov;88(21):12472-84. doi: 10.1128/JVI.01971-14. Epub 2014 Aug 20.

10.

Coat as a dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking.

Bilkova E, Forstova J, Abrahamyan L.

Viruses. 2014 Jul 23;6(7):2899-937. doi: 10.3390/v6072899. Review.

11.

Cellular unfolded protein response against viruses used in gene therapy.

Sen D, Balakrishnan B, Jayandharan GR.

Front Microbiol. 2014 May 26;5:250. doi: 10.3389/fmicb.2014.00250. eCollection 2014. Review.

12.

Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus.

Nicolson SC, Samulski RJ.

J Virol. 2014 Apr;88(8):4132-44. doi: 10.1128/JVI.02660-13. Epub 2014 Jan 29.

13.

Oversized AAV transductifon is mediated via a DNA-PKcs-independent, Rad51C-dependent repair pathway.

Hirsch ML, Li C, Bellon I, Yin C, Chavala S, Pryadkina M, Richard I, Samulski RJ.

Mol Ther. 2013 Dec;21(12):2205-16. doi: 10.1038/mt.2013.184. Epub 2013 Aug 13.

14.

A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.

Koirala A, Conley SM, Naash MI.

Biomaterials. 2013 Sep;34(29):7158-67. doi: 10.1016/j.biomaterials.2013.06.002. Epub 2013 Jun 22. Review.

15.

Adeno-associated virus capsid antigen presentation is dependent on endosomal escape.

Li C, He Y, Nicolson S, Hirsch M, Weinberg MS, Zhang P, Kafri T, Samulski RJ.

J Clin Invest. 2013 Mar;123(3):1390-401. doi: 10.1172/JCI66611. Epub 2013 Feb 1.

16.

Activation of the cellular unfolded protein response by recombinant adeno-associated virus vectors.

Balakrishnan B, Sen D, Hareendran S, Roshini V, David S, Srivastava A, Jayandharan GR.

PLoS One. 2013;8(1):e53845. doi: 10.1371/journal.pone.0053845. Epub 2013 Jan 8.

17.
18.

Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry.

Popa-Wagner R, Porwal M, Kann M, Reuss M, Weimer M, Florin L, Kleinschmidt JA.

J Virol. 2012 Sep;86(17):9163-74. doi: 10.1128/JVI.00282-12. Epub 2012 Jun 13.

19.

Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Seto JT, Ramos JN, Muir L, Chamberlain JS, Odom GL.

Curr Gene Ther. 2012 Jun;12(3):139-51. Review.

20.

Intracellular transport of recombinant adeno-associated virus vectors.

Nonnenmacher M, Weber T.

Gene Ther. 2012 Jun;19(6):649-58. doi: 10.1038/gt.2012.6. Epub 2012 Feb 23. Review.

Supplemental Content

Support Center